Drug therapy in patients with severe forms of sickle cell anemia: A nonrandomized clinical trial of combining l-carnitine with hydroxycarbamide therapy
BACKGROUND AND AIM: Combining Hydroxycarbamide (hydroxyurea) therapy and L-Carnitine (HU+LC) was proved effective and tolerable in patients with thalassemia intermedia; however, its role in sickle cell anemia (SCA) was not investigated. This study aimed to assess various aspects of treatment with HU...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Serija: | Journal of Applied Hematology |
| Teme: | |
| Online pristup: | http://www.jahjournal.org/article.asp?issn=1658-5127;year=2022;volume=13;issue=4;spage=237;epage=248;aulast=A. |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|